NAN FUNG TRINITY (HK) Ltd
Sector Allocation
- Healthcare34.0%$344.2M
- Technology13.5%$136.6M
- Materials13.2%$133.4M
- Consumer Discretionary11.8%$119.6M
- Other11.7%$118.8M
- Communication Services7.6%$76.6M
- Real Estate4.5%$45.5M
- Industrials2.4%$24.5M
- Financials1.3%$13.5M
AUM History
13fpro.ai/research/fund/nan-fung-trinity-hk-ltd-1781880
Conviction and streaks
Stable · top 10 = 40.5%From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.
Largest positions — Q2 2026
AMD
$67.8MAMCR
$52.0MPPG
$48.2MGEHC
$40.9MNVDA
$36.1MHD
$35.2MKT
$33.8M- ISHARES$33.7M
- ISHARES$33.0M
OC
$29.6MUNH
$28.4MAPD
$28.3M- ISHARES$27.7M
AMX
$27.4MMIRM
$27.2MDHR
$24.1MTRVI
$22.6MMETA
$21.0MPTGX
$19.7MABVX
$18.9M
Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.
13fpro.ai/research/fund/nan-fung-trinity-hk-ltd-1781880
NAN FUNG TRINITY (HK) Ltd 13F holdings — Q2 2026
$1.0B portfolio (+11.2% QoQ) · 55 holdings · Q2 2026 13F · top 10 are 41% of the stock portfolio
$67.8M
6.7% of stocks
-28%This quarter—Since Q-end—HeldAIQuality79.8#31Est. buy—$52.0M
5.1% of stocks
+7%This quarter—Since Q-end—HeldAIQuality—Est. buy—$48.2M
4.8% of stocks
No changeThis quarter—Since Q-end—HeldAIQuality61.6#773Est. buy—$40.9M
4.0% of stocks
+203%This quarter—Since Q-end—HeldAIQuality59.6#921Est. buy—$36.1M
3.6% of stocks
-22%This quarter—Since Q-end—HeldAIQuality86.0#3Est. buy—$35.2M
3.5% of stocks
+37%This quarter—Since Q-end—Held$33.8M
3.3% of stocks
+0.3%This quarter—Since Q-end—HeldAIQuality—Est. buy—- 8
ISHARES TR - MSCI INDONIA ETF
$33.7M
3.3% of stocks
+33%This quarter—Since Q-end—HeldAIQuality—Est. buy— - 9
ISHARES TR - MBS ETF
$33.0M
3.3% of stocks
No changeThis quarter—Since Q-end—HeldAIQuality—Est. buy— $29.6M
2.9% of stocks
+37%This quarter—Since Q-end—Held
| # | Company | Value | Weight | This quarter | Since Q-end | Held | AI quality | Est. buy | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | $67.8M | 6.7% | -28% | — | — | 79.8#31 | — | ||
| 2 | $52.0M | 5.1% | +7% | — | — | — | — | ||
| 3 | $48.2M | 4.8% | No change | — | — | 61.6#773 | — | ||
| 4 | $40.9M | 4.0% | +203% | — | — | 59.6#921 | — | ||
| 5 | $36.1M | 3.6% | -22% | — | — | 86.0#3 | — | ||
| 6 | $35.2M | 3.5% | +37% | — | — | AI quality score is Pro: unlock with a free trial | — | ||
| 7 | $33.8M | 3.3% | +0.3% | — | — | — | — | ||
| 8 | ISHARES TR - MSCI INDONIA ETF | $33.7M | 3.3% | +33% | — | — | — | — | |
| 9 | ISHARES TR - MBS ETF | $33.0M | 3.3% | No change | — | — | — | — | |
| 10 | $29.6M | 2.9% | +37% | — | — | AI quality score is Pro: unlock with a free trial | — |
All holdings — NAN FUNG TRINITY (HK) Ltd (Q2 2026)
55 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.
| # | Company | Held | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11 | UNITEDHEALTH GROUP INC | Healthcare | $28.4M | 2.8% | 68K | -34% | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 12 | Air Products & Chemicals, Inc. | Materials | $28.3M | 2.8% | 97K | — | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 13 | — | ISHARES TR - CORE S&P MCP ETFetf/fund | — | $27.7M | 2.7% | 359K | — | — | — | 13F |
| 14 | AMERICA MOVIL SAB DE CV/adr | Communication Services | $27.4M | 2.7% | 1.06M | -20% | — | — | 13F | |
| 15 | Mirum Pharmaceuticals, Inc. | Healthcare | $27.2M | 2.7% | 233K | — | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 16 | DANAHER CORP /DE/ | Healthcare | $24.1M | 2.4% | 127K | +28% | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 17 | Trevi Therapeutics, Inc. | Healthcare | $22.6M | 2.2% | 1.21M | +6% | — | — | 13F | |
| 18 | Meta Platforms, Inc. | Technology | $21.0M | 2.1% | 37K | +146% | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 19 | Protagonist Therapeutics, Inc | Healthcare | $19.7M | 1.9% | 161K | — | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 20 | Abivax S.A.adr | Healthcare | $18.9M | 1.9% | 142K | +10% | — | — | 13F | |
| 21 | — | SPDR SERIES TRUST - ST STR SP HOMEetf/fund | — | $17.9M | 1.8% | 155K | — | — | — | 13F |
| 22 | JD.com, Inc.adr | Consumer Discretionary | $16.6M | 1.6% | 650K | — | — | — | 13F | |
| 23 | BridgeBio Pharma, Inc. | Healthcare | $16.3M | 1.6% | 219K | — | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 24 | MP Materials Corp. / DE | Materials | $15.9M | 1.6% | 283K | — | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 25 | PDD Holdings Inc.adr | Consumer Discretionary | $15.8M | 1.6% | 208K | +36% | — | — | 13F | |
| 26 | $SRRK | Scholar Rock Holding Corp | Healthcare | $15.7M | 1.6% | 285K | — | |||
| 27 | $WBD | Warner Bros. Discovery, Inc. | Communication Services | $15.3M | 1.5% | 576K | — | |||
| 28 | $IMNM | Immunome Inc. | Healthcare | $15.1M | 1.5% | 715K | — | |||
| 29 | $XENE | Xenon Pharmaceuticals Inc. | Healthcare | $15.0M | 1.5% | 248K | — | |||
| 30 | $IREN | IREN Ltd | Financials | $13.5M | 1.3% | 295K | New | |||
| 31 | $KURA | Kura Oncology, Inc. | Healthcare | $12.9M | 1.3% | 1.17M | +10% | |||
| 32 | $BCAX | Bicara Therapeutics Inc. | Healthcare | $12.7M | 1.3% | 428K | — | |||
| 33 | $ARE | ALEXANDRIA REAL ESTATE EQUITIES, INC. | Real Estate | $12.6M | 1.3% | 239K | — | |||
| 34 | $HON | HONEYWELL INTERNATIONAL INC | Industrials | $12.3M | 1.2% | 55K | -34% | |||
| 35 | $HONA | Honeywell Aerospace Inc. | Industrials | $12.2M | 1.2% | 55K | New | |||
| 36 | $VOR | Vor Biopharma Inc. | Healthcare | $11.9M | 1.2% | 647K | New | |||
| 37 | $FLEX | FLEX LTD. | Technology | $11.7M | 1.2% | 72K | New | |||
| 38 | $CRH | CRH PUBLIC LTD CO | Materials | $11.4M | 1.1% | 107K | New | |||
| 39 | $SVRA | Savara Inc | Healthcare | $11.3M | 1.1% | 1.84M | — | |||
| 40 | $CELC | Celcuity Inc. | Healthcare | $10.9M | 1.1% | 104K | — | |||
| 41 | $BXP | BXP, Inc. | Real Estate | $8.1M | 0.8% | 122K | — | |||
| 42 | $KRC | KILROY REALTY CORP | Real Estate | $7.9M | 0.8% | 211K | — | |||
| 43 | $PCVX | Vaxcyte, Inc. | Healthcare | $7.1M | 0.7% | 123K | — | |||
| 44 | $SLG | SL GREEN REALTY CORP | Real Estate | $6.9M | 0.7% | 133K | -2% | |||
| 45 | $ZLAB | Zai Lab Ltd | Healthcare | $6.6M | 0.7% | 346K | — | |||
| 46 | $ABEO | ABEONA THERAPEUTICS INC. | Healthcare | $5.9M | 0.6% | 957K | — | |||
| 47 | $VNO | VORNADO REALTY TRUST | Real Estate | $5.7M | 0.6% | 144K | — | |||
| 48 | $QURE | uniQure N.V. | Healthcare | $5.3M | 0.5% | 115K | — | |||
| 49 | $CLYM | Climb Bio, Inc. | Healthcare | $4.7M | 0.5% | 361K | -14% | |||
| 50 | $BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | $4.5M | 0.4% | 450K | New | |||
| 51 | $ESRT | Empire State Realty Trust, Inc. | Real Estate | $4.3M | 0.4% | 801K | — | |||
| 52 | $AVTX | Avalo Therapeutics, Inc. | Healthcare | $3.5M | 0.3% | 189K | — | |||
| 53 | — | ISHARES TR - INTL SEL DIV ETF | — | $3.2M | 0.3% | 78K | — | |||
| 54 | — | SPDR SERIES TRUST - ST STR SP500DIV | — | $3.2M | 0.3% | 68K | — | |||
| 55 | $GERN | GERON CORP | Healthcare | $2.8M | 0.3% | 2.22M | +62% |
What changed in Q2 2026
Against the previous quarter's 13F: 6 new, 13 added to, 7 trimmed, 13 sold out. Share-count changes; largest moves by dollar size first.
New positions (6)
$IRENIREN Ltd$13.5M
first bought this quarter
$HONAHoneywell Aerospace Inc.$12.2M
first bought this quarter
$VORVor Biopharma Inc.$11.9M
first bought this quarter
$FLEXFLEX LTD.$11.7M
first bought this quarter
$CRHCRH PUBLIC LTD CO$11.4M
first bought this quarter
$BCRXBIOCRYST PHARMACEUTICALS INC$4.5M
first bought this quarter
Added to (13)
now $40.9M
now $21.0M
now $35.2M
- ISHARES TR - MSCI INDONIA ETF+33%
now $33.7M
now $29.6M
now $24.1M
+7 more in the Excel export
Holdings by quarter
Every 13F NAN FUNG TRINITY (HK) Ltd has filed, 26 earlier quarters. Pick one to see what it held then.
Portfolio Overview
NAN FUNG TRINITY (HK) Ltd disclosed 55 positions worth $1.0B in its Form 13F-HR for Q2 2026, led by $AMD (ADVANCED MICRO DEVICES INC) at 6.7% of the equity portfolio, followed by $AMCR and $PPG. During the quarter the fund opened 6 new positions and exited 13 — including a new stake in $IREN. The portfolio is most concentrated in Healthcare (34.0% of disclosed assets). All figures are sourced directly from NAN FUNG TRINITY (HK) Ltd’s Form 13F-HR filing with the SEC under CIK 1781880.
Funds like this
managers whose biggest positions overlap NAN FUNG TRINITY (HK) Ltd'sBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
AI-Powered Hedge Fund Analysis: NAN FUNG TRINITY (HK) Ltd
13F Pro is an AI hedge fund tracker and stock research platform. For NAN FUNG TRINITY (HK) Ltd (SEC CIK: 1781880), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in NAN FUNG TRINITY (HK) Ltd's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.